Q&A: When Should a Patient do Biomarker Retesting? – Targeted Therapies in Lung Cancer 2023

Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This includes a Q&A with the audience and a presentation by a patient advocate, Ivy Elkins.

In this video, Drs. Stephen Liu and Misako Nagasaka discuss when patients should consider biomarker retesting, and briefly compare pralsetinib and selpercatinib.

For more, please visit http://cancerGRACE.org/.
To join the conversation, visit https://cancergrace.org/forum.

BenSound File Name: Sweet (BenSound.com)
BenSound License #: DSSHUIYGV4VQCETM

Thank you to our sponsors: #Takeda #Janssen #Lilly #Genentech #Mirati #ExactSciences #BMS #GEHealthcare.